Il temazepam è una benzodiazepina soggetta a prescrizione medica, utilizzata per il trattamento a breve termine dell’insonnia grave negli adulti quando i problemi del sonno sono invalidanti o causano un disagio marcato. Può causare tolleranza, dipendenza fisica, sintomi di astinenza e dipendenza patologica, ma si tratta di concetti correlati, non intercambiabili, e non sono conseguenze inevitabili per chiunque lo assuma. Il sostegno e il trattamento devono basarsi sui sintomi effettivi, sui rischi e sugli obiettivi della persona.
Risorse
- Lader, M. (2011). Benzodiazepines revisited—will we ever learn? Addiction, 106(12), 2086–2109.
- MedlinePlus. (n.d.). *Temazepam*. National Library of Medicine.
- National Institute on Drug Abuse. (n.d.). *Benzodiazepines and opioids*. National Institutes of Health.
- Substance Abuse and Mental Health Services Administration. (2023). *Key substance use and mental health indicators in the United States: Results from the 2022 National Survey on Drug Use and Health*. U.S. Department of Health and Human Services.
- U.S. Food and Drug Administration. (2020). *FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class*. U.S. Department of Health and Human Services.
- Baandrup, L., Fagerlund, B., Gluud, C., & Jennum, P. (2018). *Sedative hypnotics for sleep problems in adults with mental disorders* (Cochrane Review). Cochrane Database of Systematic Reviews.
- Ashton, H. (2002). Benzodiazepines: How they work and how to withdraw (The Ashton Manual). The University of Newcastle.
- Temazepam 10 mg and 20 mg tablets: current patient information leaflet. Electronic Medicines Compendium.
- National Institute for Health and Care Excellence. (2022). Medicines associated with dependence or withdrawal symptoms: Safe prescribing and withdrawal management for adults (NG215).
- Temazepam tablets: current summary of product characteristics. Electronic Medicines Compendium.
- FindTreatment.gov. (findtreatment.gov).
- Finding Help for Co-Occurring Substance Use and Mental Disorders – National Institute of Mental Health (NIMH). (www.nimh.nih.gov).
- National Institute on Drug Abuse. (2020). Benzodiazepines and opioids.
- Centers for Disease Control and Prevention. (2024). *Prescription opioid and benzodiazepine medications and occupational safety and health*. National Institute for Occupational Safety and Health.
- StatPearls. (2025). *Benzodiazepine withdrawal*. StatPearls Publishing.
- World Health Organization. (n.d.). *International classification of diseases (ICD-11): Disorders due to substance use*.


